|
AGK expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.54285481560146E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.36689565116899E-11 |
| Normal-vs-Stage2 |
1.153230E-04 |
| Normal-vs-Stage3 |
3.23389981460309E-10 |
| Normal-vs-Stage4 |
3.51569999779144E-08 |
| Stage1-vs-Stage2 |
8.054200E-01 |
| Stage1-vs-Stage3 |
6.480400E-01 |
| Stage1-vs-Stage4 |
8.858000E-01 |
| Stage2-vs-Stage3 |
6.071200E-01 |
| Stage2-vs-Stage4 |
7.547800E-01 |
| Stage3-vs-Stage4 |
8.335200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.14352971536391E-13 |
| Normal-vs-AfricanAmerican |
5.579700E-04 |
| Normal-vs-Asian |
5.994600E-01 |
| Caucasian-vs-AfricanAmerican |
1.013170E-01 |
| Caucasian-vs-Asian |
9.558000E-02 |
| AfricanAmerican-vs-Asian |
3.756200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.71462885293295E-13 |
| Normal-vs-Female |
8.14009970540042E-10 |
| Male-vs-Female |
2.528800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.721790E-01 |
| Normal-vs-Age(41-60Yrs) |
1.57790003285641E-10 |
| Normal-vs-Age(61-80Yrs) |
2.79332112995689E-13 |
| Normal-vs-Age(81-100Yrs) |
2.77809999449374E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.703240E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.950300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.074200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.481570E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.978300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.426650E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.036500E-03 |
| Normal-vs-Grade 2 |
8.37929725605591E-11 |
| Normal-vs-Grade 3 |
1.28475008409623E-12 |
| Normal-vs-Grade 4 |
9.56070000945886E-09 |
| Grade 1-vs-Grade 2 |
5.360000E-01 |
| Grade 1-vs-Grade 3 |
4.494800E-01 |
| Grade 1-vs-Grade 4 |
4.667600E-01 |
| Grade 2-vs-Grade 3 |
3.580800E-01 |
| Grade 2-vs-Grade 4 |
5.157400E-01 |
| Grade 3-vs-Grade 4 |
9.934600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62503344114384E-12 |
| Normal-vs-ccB subtype |
3.04009999951838E-07 |
| ccA subtype-vs-ccB subtype |
8.636600E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.59790008686423E-10 |
| Normal-vs-N1 |
1.726240E-01 |
| N0-vs-N1 |
3.062000E-01 |
|
|
